Shruti Jolly Appointed Medical Director in Lansing

The University of Michigan Health-Sparrow Herbert-Herman Cancer Center has named a new medical director.

Updated on Oct. 12, 2026 in People

Shruti Jolly Appointed Medical Director in Lansing

Live Poll

Do you trust that local hospital leadership changes lead to better care in your community?

Dr. Shruti Jolly has assumed the role of Medical Director at the University of Michigan Health-Sparrow Herbert-Herman Cancer Center. She steps into the leadership position held by Gordan Srkalovic, who will continue to serve as the Director of Precision Oncology.

Why it matters

This appointment represents a planned leadership transition for the Lansing-based cancer center. The change in medical oversight ensures ongoing management of oncology services as the center prepares for Srkalovic's future departure.

Dr. Shruti Jolly brings dual credentials as an M.D. and an MBA to her new role as the center's Medical Director. Her appointment follows her previous tenure as a professor of radiation oncology at the University of Michigan.

The players

Shruti Jolly

Shruti Jolly is a physician and professor of radiation oncology at the University of Michigan who now serves as the Medical Director at the University of Michigan Health-Sparrow Herbert-Herman Cancer Center.

Gordan Srkalovic

Gordan Srkalovic is the Director of Precision Oncology who is preparing to retire from the University of Michigan Health-Sparrow Herbert-Herman Cancer Center.

University of Michigan Health-Sparrow Herbert-Herman Cancer Center

This is a Lansing-based medical facility providing specialized cancer care and research services.

The details

Shruti Jolly began her new responsibilities as part of a formal leadership transition at the facility. She will work alongside Gordan Srkalovic, who remains in his post as Director of Precision Oncology to support the transition until his retirement.

Shruti Jolly began her role as Medical Director on October 1, 2026.
Gordan Srkalovic is scheduled to retire from his position on December 31, 2026.

Market Landscape

The appointment of a new medical director reflects the broader administrative consolidation occurring within regional healthcare systems. This shift positions the cancer center to maintain continuity of care as it integrates further into the University of Michigan Health network.

Patients and their families can expect continued service delivery as the cancer center manages this planned transition. The shift in medical leadership aims to ensure stable operations for those accessing specialized oncology care in the Lansing area.

The takeaway

Leadership changes in specialized medical centers are often coordinated well in advance to prevent service disruptions. Patients should monitor official communications from the center for any future updates regarding oncology program changes.